S&P 500 7536.17 -0.10%
NASDAQ 26093.61 -0.43%
TASI 10808.43 -0.42%
Oil (WTI) 71.96 -0.17%
Oil (Brent) 76.44 +0.18%
VIX 15.68 -1.01%
Gold 4110.90 -0.72%
USD/SAR 3.75 +0.01%

Humana Inc.

HUM · Healthcare · · USD
393.85 USD
0.00 (-0.98%)
● Updated 2026-07-10 18:08 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score STRONG BUY Mid-term (Position)

81
/ 100
Technical 75
Trend & RS 99
Momentum 91
Fundamental 78
Macro 67
Liquidity 37
ComponentScoreWeight
Technical 75.0 20%
Trend & RS 99.2 30%
Momentum 90.6 15%
Fundamental 77.8 10%
Macro 67.2 20%
Liquidity 36.7 5%

Trade Setup

Entry 395.56
Stop Loss 370.00 (6.5%)
Target 1 (1:1) 421.12 (+6.5%)
Target 2 (2:1) 446.68 (+12.9%)
ATR(14) 12.78 (3.2%)
Risk per Share 25.56
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 48.2 -0.07
Momentum 90.6 +1.63
Quality 30.2 -0.79
Composite 56.3

Quality Scores

Piotroski F-Score 7 /9 — Strong
✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score Insufficient Data

Valuation vs Peers Fair Value

MetricStockSectorvs Peers
P/E Ratio 41.9 22.0 +91% above
P/B Ratio 2.5 4.0 Below
Dividend Yield 89.0% 1.5% Above avg

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value
276.68
vs
Market Price
393.85
Upside
-29.8%
Margin of Safety -42.3%
Stage 1 PV (5yr FCF)6,661,963,552
Terminal Value PV26,556,580,971
Total Enterprise Value33,218,544,523

Assumptions

Base FCF901,902,008
Growth Rate (5yr)23.5%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.8%
Recommended Size
52.28%
Full Kelly
26.14%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 81/100. Estimated win rate 64%, avg win 9.9%, avg loss 3.4%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG BUY

3
Bullish Signals
1
Bearish Signals
68.97
RSI(14)
19.6434
MACD

Relative Strength (RS) IMPROVING

97
/ 99
RS Rating
✓ O'Neil PASS (≥80)
RS vs SPY ↑ RISING (+89.9% vs SPY 3M)
RS vs Sector OUTPERFORMING (Healthcare)
RS New High No (6d since high)
Sector Outperformance +95.6% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

IndicatorValueSignal
Rsi 68.97 NEUTRAL
Macd 19.6434 BEARISH
Ma Cross 331.12 / 254.68 GOLDEN CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 0.12x LOW

Key Levels

LevelPrice
52-Week High415.00
Bollinger Upper413.65
SMA(200)254.68
SMA(50)331.12
SMA(20)381.12
Current Price393.85
Bollinger Lower348.58
52-Week Low163.11
ATR(14)12.78

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence
100%
Acc: 0.0  |  Dist: 0.0  |  Markup: 2.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-07-06 Normal 0.93x Normal bar — no special VSA pattern
2026-07-07 No Demand 0.57x Low volume, narrow spread, weak close — no buying interest
2026-07-08 Normal 0.82x Normal bar — no special VSA pattern
2026-07-09 Normal 0.85x Normal bar — no special VSA pattern
2026-07-10 No Supply 0.12x Low volume, narrow spread, firm close — no selling pressure

Ichimoku Cloud BULLISH

LineValueStatus
Tenkan-sen (9) 396.27 Above Kijun
Kijun-sen (26) 367.72 Base line
Senkou A 382.00 Leading span A
Senkou B 314.20 Leading span B
Cloud 314.20 – 382.00 Bullish (Green)
Price vs Cloud 395.56 Above Cloud
Chikou Span 326.77 Bullish
Alignment Score 4/4 BULLISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BULLISH FADING
BB: 348.58 – 413.65  |  KC: 361.3 – 400.94

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Regular Bearish RSI 7
Regular Bearish MACD 7
Regular Bearish RSI 18

Anchored VWAP

VWAP: 272.25 Anchor: 2026-03-20 (52w Low) ABOVE AVWAP +45.3%

Heikin-Ashi Trend

WEAKLY BEARISH Full data via /api/advanced/HUM

Valuation

MetricValue
Market Cap47.29B
P/E (TTM)41.94
Forward P/EN/A
P/B2.55
EPS9.39

Financial Health

MetricValue
Revenue Growth23.5%
Profit Margin0.8%
ROE6.3%
Debt/Equity77.07
Current Ratio1.77
Dividend Yield89.0%
Payout RatioN/A
Beta0.72

Trading Data

393.85
Open
393.85
Day High
393.85
Day Low
152.8K
Volume (0.1x avg)

Recent News (8)

UNH Showered Owners With Cash. The Stock Did Not Cooperate
Trefis · 2026-07-10
The Main Reason Behind Buying UnitedHealth Before July 16
24/7 Wall St. · 2026-07-10
Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”
24/7 Wall St. · 2026-07-09
The Real Price Of UnitedHealth Stock Isn't On Today's Label
Trefis · 2026-07-09
Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart
Simply Wall St. · 2026-07-08
UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings?
Zacks · 2026-07-08
Humana Earnings Preview: What to Expect
Barchart · 2026-07-07
What CVS Health Stock Was Telling You About Its Three-Dollar Earnings Prize
Trefis · 2026-07-06

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —